91 related articles for article (PubMed ID: 1472031)
1. Triflavin, an RGD-containing antiplatelet peptide, binds to GpIIIa of ADP-stimulated platelets.
Sheu JR; Teng CM; Huang TF
Biochem Biophys Res Commun; 1992 Dec; 189(2):1236-42. PubMed ID: 1472031
[TBL] [Abstract][Full Text] [Related]
2. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
Huang TF; Sheu JR; Teng CM
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
[TBL] [Abstract][Full Text] [Related]
3. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
4. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
5. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
6. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
[TBL] [Abstract][Full Text] [Related]
7. Ex-vivo and in-vivo antithrombotic effect of triflavin, an RGD-containing peptide.
Sheu JR; Huang TF
J Pharm Pharmacol; 1994 Jan; 46(1):58-62. PubMed ID: 8201528
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom.
Huang TF; Sheu JR; Teng CM
Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595
[TBL] [Abstract][Full Text] [Related]
9. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.
Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193
[TBL] [Abstract][Full Text] [Related]
10. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.
Savage B; Marzec UM; Chao BH; Harker LA; Maraganore JM; Ruggeri ZM
J Biol Chem; 1990 Jul; 265(20):11766-72. PubMed ID: 2365698
[TBL] [Abstract][Full Text] [Related]
11. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.
Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J
Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
Huang TF; Wang WJ; Teng CM; Ouyang C
Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
[TBL] [Abstract][Full Text] [Related]
13. Chemical cross-linking of arginyl-glycyl-aspartic acid peptides to an adhesion receptor on platelets.
D'Souza SE; Ginsberg MH; Lam SC; Plow EF
J Biol Chem; 1988 Mar; 263(8):3943-51. PubMed ID: 3346230
[TBL] [Abstract][Full Text] [Related]
14. Arg-Gly-Asp-dependent occupancy of GPIIb/IIIa by applaggin: evidence for internalization and cycling of a platelet integrin.
Wencel-Drake JD; Frelinger AL; Dieter MG; Lam SC
Blood; 1993 Jan; 81(1):62-9. PubMed ID: 8417803
[TBL] [Abstract][Full Text] [Related]
15. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
Rahman S; Lu X; Kakkar VV; Authi KS
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
[TBL] [Abstract][Full Text] [Related]
16. Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets.
McLane MA; Kowalska MA; Silver L; Shattil SJ; Niewiarowski S
Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):429-36. PubMed ID: 8042985
[TBL] [Abstract][Full Text] [Related]
17. Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata.
Karczewski J; Endris R; Connolly TM
J Biol Chem; 1994 Mar; 269(9):6702-8. PubMed ID: 8120028
[TBL] [Abstract][Full Text] [Related]
18. Modulation of an RGDS binding site on the platelet membrane glycoprotein IIb-IIIa complex.
Santoro SA; Lawing WJ
Biochem Biophys Res Commun; 1989 Apr; 160(1):189-95. PubMed ID: 2712830
[TBL] [Abstract][Full Text] [Related]
19. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the binding character of triflavin on resting and activated alpha(IIb)beta(3) integrin in human platelets by electron microscopy.
Chuang WJ; Wu CH; Huang HN; Chen SH; Hsiao G; Lin CH; Sheu JR
Thromb Res; 2003 Jan; 109(1):37-46. PubMed ID: 12679130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
